• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受经皮腔内血管成形术(PTA)的严重肢体缺血患者临床结局的预测参数:一项系统评价

Predictive Parameters for Clinical Outcome in Patients with Critical Limb Ischemia Who Underwent Percutaneous Transluminal Angioplasty (PTA): A Systematic Review.

作者信息

Schreuder Sanne M, Hendrix Yvette M G A, Reekers Jim A, Bipat Shandra

机构信息

Department of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

出版信息

Cardiovasc Intervent Radiol. 2018 Jan;41(1):1-20. doi: 10.1007/s00270-017-1796-9. Epub 2017 Sep 18.

DOI:10.1007/s00270-017-1796-9
PMID:28924874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5735197/
Abstract

PURPOSE

To identify possible risk factors in predicting clinical outcome in critical limb ischemia (CLI) patients undergoing percutaneous transluminal angioplasty (PTA).

MATERIALS AND METHODS

PubMed and EMBASE were searched for studies analyzing CLI and clinical outcome after PTA from January 2006 to April 2017. Outcome measures were ulcer healing, amputation free survival (AFS)/limb salvage and overall survival. Data on predictive factors for ulcer healing, AFS/limb salvage and survival were extracted.

RESULTS

Ten articles with a total of 2448 patients were included, all cohorts and based on prospective-designed databases. For ulcers, it seems that complete healing can be achieved in most of the patients within 1 year. No significant predictive factors were found. AFS/limb salvage: AFS rates for 1, 2 and 3 years ranged from 49.5 to 75.2%, 37 to 58% and 22 to 59%, respectively. Limb salvage rates for 1, 2 and 3 years ranged from 71 to 95%, 54 to 93.3% and 32 to 92.7%, respectively. All studies had different univariate and multivariate outcomes for predictive factors; however, age and diabetes were significant predictors in at least three studies. Survival: Survival rates for 1, 2 and 3 years ranged from 65.4 to 91.5%, 45.7 to 76% and 37.3 to 83.1%, respectively. Different predictive factors were found; however, age was found in 2 out of 5 studies reporting on predictive factors.

CONCLUSIONS

In several studies two factors, age and diabetes, were found as predictive factors for AFS/limb salvage and survival in patients with CLI undergoing PTA. Therefore, we believe that these factors should be taken into account in future research.

LEVEL OF EVIDENCE

Level 2a.

摘要

目的

确定预测接受经皮腔内血管成形术(PTA)的严重肢体缺血(CLI)患者临床结局的可能风险因素。

材料与方法

检索PubMed和EMBASE,查找2006年1月至2017年4月期间分析CLI及PTA术后临床结局的研究。结局指标为溃疡愈合、无截肢生存(AFS)/肢体挽救及总生存。提取溃疡愈合、AFS/肢体挽救及生存的预测因素数据。

结果

纳入10篇文章,共2448例患者,均为队列研究且基于前瞻性设计数据库。对于溃疡,似乎大多数患者在1年内可实现完全愈合。未发现显著预测因素。AFS/肢体挽救:1年、2年和3年的AFS率分别为49.5%至75.2%、37%至58%和22%至59%。1年、2年和3年的肢体挽救率分别为71%至95%、54%至93.3%和32%至92.7%。所有研究对于预测因素的单变量和多变量结局各不相同;然而,年龄和糖尿病在至少三项研究中是显著预测因素。生存:1年、2年和3年的生存率分别为65.4%至91.5%、45.7%至76%和37.3%至83.1%。发现了不同的预测因素;然而,在报告预测因素的5项研究中有2项发现了年龄因素。

结论

在多项研究中,年龄和糖尿病这两个因素被发现是接受PTA的CLI患者AFS/肢体挽救及生存的预测因素。因此,我们认为在未来研究中应考虑这些因素。

证据水平

2a级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a7/5735197/333002cec0a6/270_2017_1796_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a7/5735197/333002cec0a6/270_2017_1796_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88a7/5735197/333002cec0a6/270_2017_1796_Fig1_HTML.jpg

相似文献

1
Predictive Parameters for Clinical Outcome in Patients with Critical Limb Ischemia Who Underwent Percutaneous Transluminal Angioplasty (PTA): A Systematic Review.接受经皮腔内血管成形术(PTA)的严重肢体缺血患者临床结局的预测参数:一项系统评价
Cardiovasc Intervent Radiol. 2018 Jan;41(1):1-20. doi: 10.1007/s00270-017-1796-9. Epub 2017 Sep 18.
2
Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.腰交感神经切除术与前列腺素类药物治疗因不可重建的外周动脉疾病导致的严重肢体缺血的比较
Cochrane Database Syst Rev. 2018 Apr 16;4(4):CD009366. doi: 10.1002/14651858.CD009366.pub2.
3
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial.在BEST-CLI试验中,女性患者的肢体截肢情况比男性患者少。
J Vasc Surg. 2025 Feb;81(2):366-373.e1. doi: 10.1016/j.jvs.2024.09.031. Epub 2024 Oct 4.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Protease activity as a prognostic factor for wound healing in venous leg ulcers.蛋白酶活性作为下肢静脉溃疡伤口愈合的预后因素。
Cochrane Database Syst Rev. 2018 Sep 1;9(9):CD012841. doi: 10.1002/14651858.CD012841.pub2.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Dressings and topical agents for treating venous leg ulcers.用于治疗下肢静脉溃疡的敷料和外用剂。
Cochrane Database Syst Rev. 2018 Jun 15;6(6):CD012583. doi: 10.1002/14651858.CD012583.pub2.
9
Hydrogel dressings for venous leg ulcers.水凝胶敷料治疗静脉性下肢溃疡。
Cochrane Database Syst Rev. 2022 Aug 5;8(8):CD010738. doi: 10.1002/14651858.CD010738.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

引用本文的文献

1
Detecting Changes in Tissue Perfusion With Hyperspectral Imaging and Thermal Imaging Following Endovascular Treatment for Peripheral Arterial Disease.应用超光谱成像和热成像技术检测外周动脉疾病血管内治疗后的组织灌注变化。
J Endovasc Ther. 2023 Jun;30(3):382-392. doi: 10.1177/15266028221082013. Epub 2022 Mar 8.
2
The short- and long-term efficacy of intravascular stenting in the treatment of intracranial artery stenosis.血管内支架置入术治疗颅内动脉狭窄的短期和长期疗效。
Am J Transl Res. 2021 Jun 15;13(6):7115-7123. eCollection 2021.
3
The Influence of Diabetes Mellitus on the Outcome of Superficial Femoral Artery Recanalization is Debatable.

本文引用的文献

1
Critical Limb Ischemia: Current Trends and Future Directions.严重肢体缺血:当前趋势与未来方向
J Am Heart Assoc. 2016 Feb 23;5(2):e002938. doi: 10.1161/JAHA.115.002938.
2
Outcomes of Isolated Tibial Endovascular Interventions for Tissue Loss in CLI Patients on Hemodialysis.血液透析的下肢动脉硬化闭塞症患者单纯胫骨血管腔内介入治疗组织缺损的疗效
J Endovasc Ther. 2015 Oct;22(5):681-9. doi: 10.1177/1526602815602074. Epub 2015 Aug 18.
3
Factors Affecting Medium-Term Outcomes After Crural Angioplasty in Critically Ischemic Legs.严重缺血性下肢行小腿血管成形术后影响中期预后的因素
糖尿病对股浅动脉再通结局的影响存在争议。
Transl Med UniSa. 2020 Feb 20;21:10-18. eCollection 2020 Jan-Apr.
Vasc Endovascular Surg. 2015 Apr-May;49(3-4):63-8. doi: 10.1177/1538574415591001. Epub 2015 Jun 16.
4
Amputation-Free Survival after Crural Percutaneous Transluminal Angioplasty for Critical Limb Ischemia.下肢经皮腔内血管成形术治疗严重肢体缺血后的无截肢生存期
Scand J Surg. 2016 Mar;105(1):42-8. doi: 10.1177/1457496915571403. Epub 2015 Feb 6.
5
Postprocedural Skin Perfusion Pressure Correlates With Clinical Outcomes 1 Year After Endovascular Therapy for Patients With Critical Limb Ischemia.肢体严重缺血患者血管内治疗后1年,术后皮肤灌注压与临床结局相关。
Angiology. 2015 Oct;66(9):862-6. doi: 10.1177/0003319715569907. Epub 2015 Feb 4.
6
Three-year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in hemodialysis patients with minor or major tissue loss.伴有轻度或重度组织缺损的血液透析患者下肢腘动脉以下血管成形术后三年的临床结局
Catheter Cardiovasc Interv. 2015 Aug;86(2):289-98. doi: 10.1002/ccd.25676. Epub 2015 Mar 16.
7
The need for improved risk stratification in chronic critical limb ischemia.改善慢性严重肢体缺血风险分层的必要性。
J Vasc Surg. 2014 Dec;60(6):1677-85. doi: 10.1016/j.jvs.2014.07.104. Epub 2014 Sep 8.
8
Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.他汀类药物治疗对严重肢体缺血患者膝下孤立性疾病血管内治疗后的疗效。
Cardiovasc Interv Ther. 2013 Oct;28(4):374-82. doi: 10.1007/s12928-013-0188-6. Epub 2013 Jun 12.
9
Outcomes following infrapopliteal angioplasty for critical limb ischemia.下肢动脉腔内成形术治疗严重肢体缺血的结果。
J Vasc Surg. 2013 Jun;57(6):1455-63; discussion 1463-4. doi: 10.1016/j.jvs.2012.10.109. Epub 2013 Feb 1.
10
Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions.腔内治疗对单纯累及腘下病变所致的临界肢体缺血患者的临床疗效。
J Vasc Surg. 2013 Apr;57(4):974-981.e1. doi: 10.1016/j.jvs.2012.10.096. Epub 2013 Feb 1.